PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 118 filers reported holding PTC THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $400,000 | +72.4% | 20,000 | +58.2% | 0.01% | +75.0% |
| Q2 2017 | $232,000 | -85.1% | 12,640 | -92.0% | 0.00% | -81.8% |
| Q1 2017 | $1,560,000 | +30.9% | 158,580 | +45.1% | 0.02% | +37.5% |
| Q4 2016 | $1,192,000 | +114.0% | 109,264 | +175.0% | 0.02% | +166.7% |
| Q3 2016 | $557,000 | -98.1% | 39,732 | -95.6% | 0.01% | -97.5% |
| Q4 2015 | $29,589,000 | +134.5% | 913,228 | +93.2% | 0.24% | +131.1% |
| Q3 2015 | $12,618,000 | -43.5% | 472,575 | +1.8% | 0.10% | -34.8% |
| Q2 2015 | $22,342,000 | -23.2% | 464,201 | -2.9% | 0.16% | -20.2% |
| Q1 2015 | $29,089,000 | -10.4% | 478,043 | -23.8% | 0.20% | -13.9% |
| Q4 2014 | $32,479,000 | +3827.3% | 627,372 | +3239.7% | 0.23% | +3733.3% |
| Q3 2014 | $827,000 | -51.6% | 18,785 | -71.2% | 0.01% | -50.0% |
| Q2 2014 | $1,707,000 | -64.5% | 65,304 | -70.8% | 0.01% | -64.7% |
| Q3 2013 | $4,807,000 | – | 224,010 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |